Clinical Trials on Dermatologic Conditions

Total 438126 results

National Cancer Institute (NCI)

Suspended

Trial of Allogeneic Reduced-Intensity, HLA-Haploidentical Bone Marrow Transplantation Followed by Graft-versus-Host-Disease (GVHD) Prophylaxis With Cyclophosphamide, Bortezomib and Maraviroc for Hematologic Malignancies in People Living With HIV

HIV | Hematologic Malignancies

United States
Duke University
National Institute of Allergy and Infectious Diseases (NIAID); Weill Medical...

Completed

Screening for Colonization With Resistant Enterobacterales in Neutropenic Patients With Hematologic Malignancies (SCENE)

Neutropenia | Hematologic Malignancy | Bloodstream Infection | Leukemia, Acute

United States
First Affiliated Hospital of Zhejiang University

Recruiting

A Study Comparing Haploidentical Hematopoietic Stem Cell Transplantations (HSCTs) From Young Non-first-degree and Older First-degree Donors in Hematological Malignancies

Leukemia

China
Nucleix Ltd.

Completed

Characterization of Methylation Patterns in Cancer and Non-Cancer cfDNA

Cancer | Hematologic Neoplasms | Solid Tumor

Israel, United States
Roswell Park Cancer Institute

Completed

Parenting Skills Intervention in Improving Medication Adherence in Pediatric Cancer Patients

Malignant Neoplasm | Parent | Hematologic and Lymphocytic Disorder | Guardian

United States
Nantes University Hospital
Jazz Pharmaceuticals

Completed

Pharmaco-economic Study of a New Medical Device Performed From the Perspective of the Hospital (Caphosol)

Hematologic Disease

France
Armando Santoro, MD

Completed

Pegfilgrastim Versus Filgrastim After High-dose Chemotherapy

Tumors | Hematological Neoplasms

Italy
Istanbul Aydın University

Recruiting

The Effect of Lavender Oil on Fatigue and Sleep Quality

Patient Participation | Hematologic Malignancies

Turkey
Masonic Cancer Center, University of Minnesota

Active, not recruiting

Reduced Intensity (RIC) Conditioning And Transplantation of HLA-Haplo-HCT

Hematologic Malignancies

United States
Memorial Sloan Kettering Cancer Center

Completed

Bulk Versus Fractionated Stem Cell Infusions in Patients With Hematologic Malignancies Undergoing Stem Cell Transplantation

Leukemia

United States
Prescient Therapeutics, Ltd.
VioQuest Pharmaceuticals

Completed

Triciribine Phosphate Monohydrate (TCN-PM, VD-0002) in Adult Patients With Advanced Hematologic Malignancies

Leukemia | Hematologic Malignancies

United States
Assiut University

Not yet recruiting

Characteristics and Outcomes of Patients With Hematological Malignancies

Haematologic Neoplasm
Shanxi Bethune Hospital

Recruiting

Clinical Study of CAR-T Technology for the Treatment of Relapsed Refractory Malignant Haematological Tumours

Hematological Malignancy

China
Institut Paoli-Calmettes
Sanofi

Not yet recruiting

PROPHYLAXIS OF GVH IN ELDERLY PATIENTS RECEIVING HAPLOIDENTICAL ALLOGENIC HEMATOPOIETIC STEM CELL TRASNPLANTATION USE OF A LOW DOSE ANTI-LYMPHOCYTIC SERUM (CASPER)

Hematological Malignancy
The Affiliated People's Hospital of Ningbo University

Recruiting

Etoposide+Cytarabine+PEG-rhG-CSF for Hematopoietic Stem Cell Mobilization in Patients With Hematological Malignancies

Hematological Malignancy

China
Centre Hospitalier Universitaire de Nice

Recruiting

Impact of Adapted Physical Activity on Patient's Recovery Following Allogeneic Stem Cell Transplantation for Hematological Malignancy (APALLO)

Haematological Malignancy

France
Children's Hospital of Fudan University

Recruiting

Nurse-initiated Conversations for Early Integration of Palliative Care in Pediatric Oncology (NiCE)

Solid Tumor | Hematological Malignancies

China
University of Missouri-Columbia

Recruiting

Membrane Target Detection for Leukemia Treatment

Hematological Malignancy

United States
Zhejiang University

Recruiting

CAR-T Cellular Therapy for B Cell Malignancies Involved in CNS

Hematological Malignancy

China
Thomas Zilli
University Hospital, Geneva

Recruiting

Total Marrow Irradiation With Volumetric Arc Therapy for Patients Unfit for a 12 Gy TBI

Haematological Malignancy

Switzerland
Rhode Island Hospital

Unknown

Molecular Testing of Cancer by Integrated Genomic, Transcriptomic, and Proteomic Analysis

Solid Tumors | Hematological Malignancies

United States
Nadine McCleary, MD, MPH
Bristol-Myers Squibb

Recruiting

SURGE: Supporting UnderRepresented Minorities in Genomics-based Cancer Trial Enrollment (Intervention)

Thoracic Cancer | Gastrointestinal Cancer | Hematologic Cancer

United States
Rigshospitalet, Denmark

Active, not recruiting

Sexual Health in Patients With Hematologic Malignancies

Quality of Life | Sexual Dysfunction | Sexuality | Psychological | Symptoms and Signs

Denmark
Gazi University

Completed

Exercise Capacity and Physical Activity Levels in Newly Diagnosed Hematologic Malignant Patients

Hematologic Malignancies

Turkey
Masonic Cancer Center, University of Minnesota
National Cancer Institute (NCI); National Institutes of Health (NIH)

Withdrawn

Treg Cells for AGVHD in Non-myeloablative UCB Transplant

Hematologic Malignancies

United States
M.D. Anderson Cancer Center
Access Pharmaceuticals, Inc.

Completed

4'-Thio-araC (Thiarabine) in Advanced Hematologic Malignancies

Leukemia

United States
Kylane Laboratoires
Eurofins Dermscan Pharmascan

Not yet recruiting

Safety and Effectiveness Clinical Evaluation of Injectable Medical Devices Viscol

Aesthetic Dermatology

Switzerland
Essenlix Corporation

Completed

Clinical Evaluation of the iMOST-X1 Hematology Analyzer - Matrix Study

Hematologic Tests

United States
Marcela V. Maus, M.D.,Ph.D.

Completed

CAR-37 T Cells In Hematologic Malignancies

Lymphoma | Lymphoma, B-Cell | Lymphoma, Non-Hodgkin | Leukemia | Lymphoma, T-Cell | Hematologic Malignancy

United States
Rambam Health Care Campus

Unknown

Effect of Smartphone App on Activity

Hematologic Malignancy | Diabetes Type 2

Israel
Joanne Kurtzberg, MD
Miltenyi Biomedicine GmbH

Completed

Unrelated Cord Blood Transplant Plus a Haplo-Identical (Half-Matched), T-Cell Depleted Stem Transplant From a Related Donor for Subjects With High Risk Malignancies

Hematologic Malignancy | Aplastic Anemia | Myelodysplastic Syndrome (MDS)

United States
Rabin Medical Center

Withdrawn

Effect of Blood Harvesting and Administration at End of CPB on Coagulation Profile

Hematologic Changes

Israel
Ribe County Hospital

Completed

Risk Stratification in Acutely Admitted Medical Patients

Hematologic Tests

Denmark
The First Affiliated Hospital of Soochow University

Recruiting

Aza With or Without ATRA in Newly Diagnosed Unfit AML or Intermediate,High or Very High Risk MDS

AML | MDS | Old Age; Debility | Hematologic Cancer

China
Peking University People's Hospital
Sanofi

Recruiting

The Optimization of Haploidentical Hematopoietic Stem Cell Transplantation

Hematological Malignancy

China
Assistance Publique - Hôpitaux de Paris

Recruiting

Predictive Markers of Response and Toxicity in Patients With a Haematological Malignancy Treated With Immunotherapy. (PRONOSTIM)

Blood Cancer

France
M.D. Anderson Cancer Center

Recruiting

Phase I/II Study of CD5 CAR Engineered IL15-Transduced Cord Blood-Derived NK Cells in Conjunction With Lymphodepleting Chemotherapy for the Management of Relapsed/Refractory Hematological Malignances

Hematological Malignancy

United States
Beckman Coulter, Inc.

Completed

DxFLEX 10C Clinical Study

Hematological Malignancy

United States, Canada, Germany
Fred Hutchinson Cancer Center
National Heart, Lung, and Blood Institute (NHLBI)

Completed

Comparing Different Methods for Collection of Comorbidity Data Per the HCT-CI

Hematopoietic Malignancy

United States
Acrotech Biopharma Inc.
Axis Clinicals Limited

Completed

Extension Study for Patients Who Had Not Met Criteria for Discontinuation in Previous Sponsored Belinostat Trials

Solid Tumor | Hematological Malignancies

United States
Fate Therapeutics

Terminated

Long-term Follow-Up Study Following Treatment With Fate Therapeutics' Engineered Cellular Immunotherapy

Hematological Malignancy

United States
Melbourne Health

Active, not recruiting

Nivolumab for Relapsed or Residual Haematological Malignancies After Allogeneic Stem Cell Transplantation (NIVALLO)

Haematological Malignancy

Australia
Acrotech Biopharma Inc.
Axis Clinicals Limited

Completed

Establish the PK of Belinostat in Patients With Wild-type, Heterozygous, and Homozygous UGT1A1*28 Genotypes

Solid Tumors | Hematological Malignancies

United States
Arcispedale Santa Maria Nuova-IRCCS
University of Modena and Reggio Emilia; GRADE Onlus

Completed

Therapeutic Education in Physical Activity (ETAF) (ETAF)

Hematologic Neoplasms

Italy
University Hospital, Strasbourg, France

Unknown

MS Detection of Somatic Mutations in Hematological Malignancies (MAHM)

Hematological Malignancy

France
Assistance Publique - Hôpitaux de Paris
Ministry of Health, France

Unknown

Economic Evaluation of Innovative Molecular Analyses in Onco-haematology

Haematological Malignancy

France
Universitaire Ziekenhuizen KU Leuven
Institutul Clinic Fundeni

Completed

A New Dosing Regimen for Posaconazole Prophylaxis in Children Based on Body Surface Area

Hematological Malignancy

Belgium, Romania
Axelar AB

Completed

A Study to Assess the Effect of Food on the Bioavailability of the IGF-1R Inhibitor AXL1717 in Patients With Advanced Malignant Tumors

Solid Tumors | Hematological Malignancies

Sweden
Tarix Pharmaceuticals

Withdrawn

Efficacy Study of a TXA127 to Reduce Acute Graft-vs-Host Disease in Subjects Undergoing Double Umbilical Cord Blood Transplantation

Hematologic Malignancies

United States
Tarix Pharmaceuticals

Withdrawn

Efficacy Study of a TXA127 to Reduce Graft-vs-Host Disease in Subjects Undergoing Allogeneic Peripheral Blood Stem Cell Transplantation

Hematologic Malignancies

United States

Clinical Trials on Dermatologic Conditions

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Macedonia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations